SAB Biotherapeutics Inc. logo

SAB Biotherapeutics Inc.

SABS | NASDAQ
Chart Builder DCF Calculator
$3.48
+$0.09 (+2.65%)
Sep 22, 2026, 10:45 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
10.5M 8.9M 56.57M 15.05M 33.21M 12.61M
Short-Term Investments
86.09M 11.86M n/a n/a n/a n/a
Long-Term Investments
46.89M n/a n/a n/a n/a n/a
Other Long-Term Assets
5.46M 482.1K 350.23K 467.69K -1 n/a
Receivables
946.78K 54.96K n/a 5.56M 8.01M 20.57M
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
3.51M 2.98M n/a n/a 6.34M n/a
Total Current Assets
101.05M 23.79M 58.91M 22.1M 50.19M 34.46M
Property-Plant & Equipment
19.4M 19.92M 24.68M 28.34M 30.95M 22.08M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
71.76M 20.4M 25.03M 28.81M 30.95M 22.08M
Total Assets
172.81M 44.2M 83.94M 50.9M 81.14M 56.54M
Account Payables
3.15M 1.69M 945.93K 3.68M 4.46M 7.38M
Deferred Revenue
n/a n/a 1.32M n/a 100K 100K
Short-Term Debt
951.37K 275.85K 1.05M 772.67K 1.8M 538.73K
Other Current Liabilities
1.55M n/a 4.49M 8.1M 8.7M 1.17M
Total Current Liabilities
10.68M 7.98M 10.81M 14.99M 26.46M 11.06M
Long-Term Debt
n/a n/a n/a 541.64K n/a 172.04K
Other Long-Term Liabilities
5.64M 6.39M 11.77M 320.93K 10.72M n/a
Total Long-Term Liabilities
10.63M 10.25M 15.83M 4.85M 16.14M 6.47M
Total Liabilities
21.32M 18.23M 26.64M 19.85M 42.59M 17.53M
Total Debt
5.95M 4.67M 5.91M 5.93M 8.52M 8.13M
Book Value
151.49M 25.97M 57.3M 31.06M 38.55M 39.01M
Book Value Per Share
2.47 2.80 10.38 7.14 14.10 14.44
Common Stock
4.77K 935 929 5.09K 4.35K 3.52K
Retained Earnings
-110.9M -124.17M -90.06M -47.87M -29.13M -11.98M
Comprehensive Income
186.51K -135.41K 26.42K n/a n/a n/a
Shareholders Equity
151.49M 25.97M 57.3M 31.06M 38.55M 39.01M
Total Investments
132.98M 11.86M n/a n/a n/a n/a

© 2026 bestshares.com. All rights reserved.